BioMarin Pharmaceuticals
BMRN
BMRN
418 hedge funds and large institutions have $14.8B invested in BioMarin Pharmaceuticals in 2017 Q1 according to their latest regulatory filings, with 62 funds opening new positions, 160 increasing their positions, 133 reducing their positions, and 47 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
1% more funds holding
Funds holding: 414 → 418 (+4)
0.69% less ownership
Funds ownership: 98.49% → 97.8% (-0.69%)
18% less funds holding in top 10
Funds holding in top 10: 11 → 9 (-2)
Holders
418
Holding in Top 10
9
Calls
$82.3M
Puts
$75.7M
Top Buyers
| 1 | +$958M | |
| 2 | +$72.5M | |
| 3 | +$71.3M | |
| 4 |
Jennison Associates
New York
|
+$55.4M |
| 5 |
ClearBridge Investments
New York
|
+$45.4M |
Top Sellers
| 1 | -$90.4M | |
| 2 | -$64.2M | |
| 3 | -$45.9M | |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
-$43.8M |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$36.6M |